🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT06627218
Recruiting Not applicable

Liberal or Adhere to Recommendations for PCC Management in Major Bleeding Following Trauma

NCT06627218 · tracked via the Priya Life Science China tracker
Sponsor
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase
Not applicable
Started
2021-01-01
Last updated
2024-10-04

Condition(s) studied

Traumatic Bleeding

Investigational drug(s) / intervention(s)

Prothrombin Complex Concentrate

Prothrombin Complex Concentrate: Adhere to Recommendations for PCC Management in Major Bleeding Following Trauma

Study summary

Severe post-traumatic bleeding remains a major challenge in trauma management . The effectiveness and safety of PCC in the treatment of major traumatic bleeding is controversial, and the indications for use are not clear. Studies on the status of PCC use and the efficacy evaluation of PCC adhere to recommendations are lacking.

Eligibility

Sex
ALL
Min age
18 Years
Max age
80 Years
Healthy volunteers
No
Inclusion Criteria: 1. Age ≥18 years old or \< 80 years old 2. Trauma treated in resuscitation unit/emergency room patient 3. Hospital admission within 24h after injury 4. Assessment of blood consumption (ABC) score ≥2 points. Exclusion Criteria: 1. PCC was used before admission 2. Anticoagulant drugs (such as low molecular weight heparin, rivaroxaban, warfarin, etc.) 3. Previous venous thrombosis (VTE, Patients with a history of coronary artery stents within 3 months of pulmonary embolism and myocardial infarction) 4. Patients with traumatic cardiac arrest in hospital 5. Women during breastfeeding, pregnancy or pregnancy 6. Patients with hemophilia A and other blood system diseases, severe liver disease, cirrhosis and other coagulation dysfunction

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Department of Emergency medicine, Second Affiliated Hospital, School of Medicine& Institute of Emergency medicine, Zhejiang University, Hangzhou Zhejiang Recruiting

More Second Affiliated Hospital, Zhejiang University, School of Medicine trials in China

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06627218 on ClinicalTrials.gov ↗ ← All trials in China